Trial intelligence / Profile preview

Phase II study of UTD1 alone or with capecitabine in metastatic or locally advanced breast cancer

ChiCTR-TRC-13004205Phase 2Completed

Sponsor

Cancer Hospital, Chinese Academy of Medical Sciences

Start

May 2012

Modality

Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules

Countries

1